SCHEMBL4929944

SCHEMBL4929944

NC(=O)c1ccccc1C(=O)c1ccc(F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.54
NPC1 O15118 4/20 0.51
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
PKM P14618 1/20 0.51
AKR1C3 P42330 3/20 0.48
CDC25B P30305 1/20 0.47
ATM Q13315 1/20 0.47
TSHR P16473 2/20 0.46
MAPK1 P28482 1/20 0.46
NR4A1 P22736 1/20 0.46
MAPT P10636 3/20 0.46
LTA4H P09960 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 2/20 0.45
HPGD P15428 2/20 0.45
POLB P06746 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1754308 0.90 AKR1C3 (0.58) NPC1ALDH1A1SMN1; SMN2AKR1C3CDC25B
Benzene SCHEMBL28318261 0.88 AKR1C3 (0.61) NPC1ALDH1A1SMN1; SMN2AKR1C3CDC25B
SCHEMBL27873928 0.86 AKR1C3 (0.65) NPC1ALDH1A1RAB9ASMN1; SMN2AKR1C3
SCHEMBL4840898 0.84 AGTR1 (0.47) AGTR1NPC1KDM4EALDH1A1RAB9A
SCHEMBL1466509 0.84 AKR1C3 (0.68) KDM4EALDH1A1AKR1C3CDC25BATM
SCHEMBL10418498 0.82 LIG1 (0.66) NPC1ALDH1A1RAB9ASMN1; SMN2PKM
SCHEMBL7849772 0.82 LIG1 (0.66) KDM4EALDH1A1RAB9APKMAKR1C3
SCHEMBL503678 0.82 AKR1C3 (0.73) KDM4EALDH1A1AKR1C3CDC25BATM
SCHEMBL7850555 0.81 AKR1C3 (0.48) KDM4EALDH1A1AKR1C3CDC25BATM
SCHEMBL2175941 0.81 NR4A1 (0.70) AGTR1NPC1KDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103145580-B Method for preparing 2-(4-fluorobenzene formyl) benzamide YELLOW RIVER DELTA JINGBO RES INST CHEMICAL IND CO LTD 2015-04-08 CN claimed
CN-103145580-B Method for preparing 2-(4-fluorobenzene formyl) benzamide YELLOW RIVER DELTA JINGBO RES INST CHEMICAL IND CO LTD 2015-04-08 CN disclosed
CN-103145580-B Method for preparing 2-(4-fluorobenzene formyl) benzamide YELLOW RIVER DELTA JINGBO RES INST CHEMICAL IND CO LTD 2015-04-08 CN disclosed
CN-103145580-B Method for preparing 2-(4-fluorobenzene formyl) benzamide YELLOW RIVER DELTA JINGBO RES INST CHEMICAL IND CO LTD 2015-04-08 CN disclosed
CN-103086899-B Synthesizing method of 2-amino-4'-fluoro-benzophenone YELLOW RIVER DELTA JINGBO CHEMICAL RES INST CO LTD 2014-09-17 CN disclosed
CN-103145580-A Method for preparing 2-(4-fluorobenzene formyl) benzamide YELLOW RIVER DELTA JINGBO CHEMICAL RES INST CO LTD 2013-06-12 CN disclosed
CN-103145580-A Method for preparing 2-(4-fluorobenzene formyl) benzamide YELLOW RIVER DELTA JINGBO CHEMICAL RES INST CO LTD 2013-06-12 CN disclosed
CN-103145580-A Method for preparing 2-(4-fluorobenzene formyl) benzamide YELLOW RIVER DELTA JINGBO CHEMICAL RES INST CO LTD 2013-06-12 CN disclosed
CN-103086899-A Synthesizing method of 2-amino-4'-fluoro-benzophenone YELLOW RIVER DELTA JINGBO CHEMICAL RES INST CO LTD 2013-05-08 CN disclosed
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-04-17 US disclosed
CN-1690042-A Preparation method of 2-amino-4' -fluoro-benzophenone ZHUANG LUOYUAN (CN) 2005-11-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor MCHR1, GPR119, MCHR2 AGTR1 146/4885NPC1 472/4885KDM4E 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.